受神經技術進步以及帕金森氏症、癲癇和慢性疼痛等神經系統疾病日益流行的推動，神經植入物市場正在經歷顯著增長。神經植入物是植入大腦或神經系統以治療各種疾病的裝置，為對常規療法沒有反應的患者提供有希望的解決方案。市場的最新發展包括引入微創手術、改進植入物設計以及整合人工智慧以獲得更好的治療效果。公司也致力於提高植入物的生物相容性，以確保長期有效性。此外，對腦機介面 (BCI) 技術日益增長的需求正在推動神經植入物的創新。該市場得到了公共和私營部門的大力投資以及增加的研究資金的支持。隨著醫療保健提供者認識到神經植入物的潛力，市場將在未來幾年繼續擴張。
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (F&B Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS), and Vagus Nerve Stimulation (VNS)), Application (Snapshot & Growth Engine, Chronic Pain, Parkinson's Disease, Epilepsy, and Others), End-User (Hospitals, Specialized Neurological Centers, and Outpatient Surgery Centers) – Industry Trends and Forecast to 2032
.
The Global Neural Implants Market size was valued at USD 2.37 USD Billion in 2024.
The Global Neural Implants Market is projected to grow at a CAGR of 12.65% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
